☆ 4.8 Meeting Abstract

SAFETY AND EFFICACY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE THERAPY IN LAMIVUDINE EXPERIENCED PATIENTS

JOURNAL OF HEPATOLOGY (2009)

期刊

JOURNAL OF HEPATOLOGY

卷 50, 期 -, 页码 S335-S336

出版社

ELSEVIER SCIENCE BV

DOI: 10.1016/S0168-8278(09)60925-9

关键词

-

类别

Gastroenterology & Hepatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Gastroenterology & Hepatology

Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice

Hidenori Toyoda, Jennifer Leong, Charles Landis, Masanori Atsukawa, Tsunamasa Watanabe, Daniel Q. Huang, Joanne Liu, Sabrina Xin Zi Quek, Toru Ishikawa, Taeang Arai, Keisuke Yokohama, Makoto Chuma, Koichi Takaguchi, Haruki Uojima, Tomonori Senoo, Hansen Dang, Mayumi Maeda, Joseph Hoang, Richard H. Le, Satoshi Yasuda, Khin N. Thin, Sally Tran, Nicholas Chien, Linda Henry, Akira Asai, Shinya Fukunishi, Ramsey Cheung, Seng Gee Lim, Huy N. Trinh, Mindie H. Nguyen

Summary: Following the switch to TAF, patients with chronic hepatitis B showed continued improvement in virologic response and ALT normalization, with no significant changes in estimated glomerular filtration rate. Patients with chronic kidney disease at baseline also showed improvement in kidney function after switching to TAF.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B

Zhihong Liu, Qinglong Jin, Yuexin Zhang, Guozhong Gong, Guicheng Wu, Lvfeng Yao, Xiaofeng Wen, Zhiliang Gao, Yan Huang, Daokun Yang, Enqiang Chen, Qing Mao, Shide Lin, Jia Shang, Huanyu Gong, Lihua Zhong, Huafa Yin, Fengmei Wang, Peng Hu, Ling Xiao, Chuan Li, Qiong Wu, Chang'an Sun, Junqi Niu, Jinlin Hou

Summary: This study compared the efficacy and safety of TMF and TDF in patients with chronic hepatitis B for 48 weeks. Results showed that TMF was non-inferior to TDF in terms of anti-HBV efficacy and demonstrated better bone and renal safety after 48 weeks of treatment.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Olympia E. Anastasiou, Florin A. Caruntu, Manuela G. Curescu, Kendal Yalcin, Ulus S. Akarca, Selim Gurel, Stefan Zeuzem, Andreas Erhardt, Stefan Lueth, George V. Papatheodoridis, Onur Keskin, Kerstin Port, Monica Radu, Mustafa K. Celen, Ramazan Idilman, Benjamin Heidrich, Ingmar Mederacke, Heiko von der Leyen, Julia Kahlhoefer, Maria von Karpowitz, Svenja Hardtke, Markus Cornberg, Cihan Yurdaydin, Heiner Wedemeyer

Summary: This study confirms that patients who undergo PEG-IFNa treatment and achieve HDV suppression have a lower risk of developing liver-related complications. Until alternative therapies become available, PEG-IFNa treatment should be recommended for patients with HDV infection.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

Scott K. Fung, Calvin Q. Pan, Grace Lai-Hung Wong, Wai-Kay Seto, Sang Hoon Ahn, Chi-Yi Chen, Hie-Won L. Hann, Maciej S. Jablkowski, Yoon Jun Kim, Cihan Yurdaydin, Cheng-Yuan Peng, Tuan Nguyen, Hiroshi Yatsuhashi, John F. Flaherty, Leland J. Yee, Frida Abramov, Hongyuan Wang, Dzhamal Abdurakhmanov, Young-Suk Lim, Maria Buti

Summary: Patients with CHB who switch from TDF to TAF show changes in lipid profiles but no significant impact on cardiovascular risk.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B

Jihye Lim, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi

Summary: Real-world data suggests that TAF and TDF have comparable efficacies in treating CHB, with similar virological responses and ALT normalization, and no higher risk of HCC.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load

Baijun Li, Zhaozhe Liu, Xing Liu, Dongchun Liu, Mingyu Duan, Ye Gu, Qiong Liu, Qiang Ma, Yushi Wei, Yan Wang

Summary: The study demonstrated that both TAF and TDF effectively prevented mother-to-child transmission of hepatitis B. TAF showed superiority in terms of renal safety and breastfeeding compared to TDF.

HEPATOLOGY INTERNATIONAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study

Young Chang, Sang-Gyune Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sae-Hwan Lee, Young-Seok Kim, Hong-Soo Kim, Hyun-Woong Lee, Suyeon Park

Summary: The study demonstrated that tenofovir disoproxil orotate (TDO) is as effective and safe as tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B. TDO treatment showed comparable virological response and improved renal function compared to TDF treatment.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients

Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim

Summary: The study compared the effects of three antiviral agents on the risk of hepatocellular carcinoma and orthotopic liver transplantation or mortality in patients with chronic hepatitis B. It was found that the outcomes of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide were statistically similar in treatment-naive patients with CHB.

HEPATOLOGY INTERNATIONAL (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation

Shao-Ming Chiu, Kuo-Chin Chang, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung Chen

Summary: This study compared the one-year retreatment efficacy and renal safety of entecavir, TDF, and TAF in patients with HBV relapse. The results showed no significant difference in virological response and ALT normalization among the three groups after 12 months of retreatment. Lower baseline levels of HBV DNA and HBsAg were independently associated with virological response at 12 months of retreatment. The TDF group had higher ALT levels at 12 months of retreatment, while the eGFR increased in the entecavir and TAF groups.

DIGESTIVE DISEASES AND SCIENCES (2023)

添加到收藏夹

Article Virology

Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate

Lilian Yan Liang, Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Amy Shuk-Man Lam, Yee-Kit Tse, Vicki Wing-Ki Hui, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Grace Lai-Hung Wong

Summary: This study evaluated the impact of switching to TAF on ALT normalization and renal safety in CHB patients and described the indications for switching to TAF. The results showed that switching to TAF significantly reduced ALT levels and increased ALT normalization rate. TAF was found to be associated with improved ALT levels and better renal safety compared to TDF dominant therapy in CHB patients. The majority of CHB patients switched to TAF due to advanced age, followed by bone disease and renal alteration.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Shahin Lockman, Sean S. Brummel, Lauren Ziemba, Lynda Stranix-Chibanda, Katie McCarthy, Anne Coletti, Patrick Jean-Philippe, Ben Johnston, Chelsea Krotje, Lee Fairlie, Risa M. Hoffman, Paul E. Sax, Sikhulile Moyo, Nahida Chakhtoura, Jeffrey S. A. Stringer, Gaerolwe Masheto, Violet Korutaro, Haseena Cassim, Blandina T. Mmbaga, Esau Joao, Sherika Hanley, Lynette Purdue, Lewis B. Holmes, Jeremiah D. Momper, Roger L. Shapiro, Navdeep K. Thoofer, James F. Rooney, Lisa M. Frenkel, K. Rivet Amico, Lameck Chinula, Judith Currier

Summary: This study compared the safety and efficacy of three antiretroviral regimens started in pregnancy. The dolutegravir-containing regimens had superior virological efficacy at delivery compared with the efavirenz-containing regimen and the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate regimen. The dolutegravir, emtricitabine, and tenofovir alafenamide fumarate regimen had the lowest frequency of composite adverse pregnancy outcomes and of neonatal deaths.

LANCET (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir

Fa-Da Wang, Jing Zhou, Lan-Qing Li, Yu-Jing Li, Meng -Lan Wang, Ya-Chao Tao, Dong-Mei Zhang, Yong-Hong Wang, En-Qiang Chen

Summary: This study aimed to assess the incidence of renal and bone impairment in chronic hepatitis B (CHB) patients with long-term tenofovir disoproxil fumarate (TDF) therapy and to identify changes in bone mineral density (BMD) and renal function after switching to entecavir (ETV) or tenofovir alafenamide (TAF). The results showed that younger CHB patients on long-term TDF therapy are at a high risk for bone and renal impairment, which can be reduced when switched to ETV or TAF.

ANNALS OF HEPATOLOGY (2023)

添加到收藏夹

Article Microbiology

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection

Toni Herta, Magdalena Hahn, Melanie Maier, Janett Fischer, Johannes Niemeyer, Mario Hoenemann, Albrecht Boehlig, Florian Gerhardt, Aaron Schindler, Jonas Schumacher, Thomas Berg, Johannes Wiegand, Florian van Boemmel

Summary: The study analyzed real-life data of patients with chronic hepatitis delta treated with BLV and TDF, showing mostly positive virologic response after 24 weeks and sustained efficacy for more than 48 weeks.

PATHOGENS (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Safety of Tenofovir Disoproxil Fumarate for Pregnant Women Facing the Coronavirus Disease 2019 Pandemic

Sonia Hernandez-Diaz, Brian T. Bateman, Loreen Straub, Yanmin Zhu, Helen Mogun, Michael Fischer, Krista F. Huybrechts

Summary: The study found that the use of tenofovir during the first trimester of pregnancy in women with HIV does not increase the risk of major congenital malformations in newborns compared to other antiretroviral therapies. The adjusted relative risk was 1.21 with a confidence interval of 0.77 to 1.90, indicating no significant difference in risk between TDF and other ART. A meta-analysis of prior studies also supported these findings with a pooled relative risk of 0.88 and a confidence interval of 0.75 to 1.03.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

添加到收藏夹

Article Microbiology

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

Ahizechukwu C. Eke, Kensuke Shoji, Brookie M. Best, Jeremiah D. Momper, Alice M. Stek, Tim R. Cressey, Mark Mirochnick, Edmund Capparelli

Summary: The pharmacokinetics of tenofovir in pregnant and postpartum women were affected by changes in apparent oral clearance and volume of distribution at steady state. These changes were primarily associated with increased body weight and enhanced renal function during pregnancy, leading to higher clearance rates compared to postpartum values. Dose adjustment of tenofovir disoproxil fumarate during pregnancy is generally not necessary, but any modifications should be made based on considerations of weight and renal function.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Correction Multidisciplinary Sciences

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study (vol 12, e0184550, 2017)

Maria Buti, Maria L. Manzano, Rosa M. Morillas, Montserrat Garcia-Retortillo, Leticia Martin, Martin Prieto, Maria L. Gutierrez, Emilio Suarez, Mariano Gomez Rubio, Javier Lopez, Pilar Castillo, Manuel Rodriguez, Jose M. Zozaya, Miguel A. Simon, Luis E. Morano, Jose L. Calleja, Maria Yebenes, Rafael Esteban

PLOS ONE (2018)

添加到收藏夹

Article Surgery

Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study

Victoria Aguilera, Tommaso Di Maira, Isabel Conde, Victoria Fornes-Ferrer, Carmen Vinaixa, Carmen Pallares, Angela Carvalho-Gomes, Almudena Cubells, Maria Garcia, Angel Rubin, Salvador Benlloch, Luisa Gonzalez-Dieguez, Jose Miguel Molina, Lorena Puchades, F. Xavier Lopez-Labrador, Martin Prieto, Marina Berenguer

TRANSPLANT INTERNATIONAL (2018)

添加到收藏夹

Letter Gastroenterology & Hepatology

Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

Carmen Vinaixa, Victoria Aguilera, Marino Blanes, Javier Maupoey, Marina Berenguer, Martin Prieto

LIVER TRANSPLANTATION (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients

Emilio Suarez, Maria Buti, Manuel Rodriguez, Martin Prieto, Juan M. Pascasio-Acevedo, Teresa Casanovas, Javier Crespo, Juan Arenas Ruiz Tapiador, Rafael Gomez-Rodriguez, Blanca Figueruela, Moises Diago, Rosa M. Morillas, Jose M. Zozaya, Jose L. Calleja, Marta Casado, Esther Molina, Javier Fuentes, Miguel A. Simon

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)

Marc Puigvehi, Agustin Albillos, Ana Viu, Manuel Hernandez-Guerra, Inmaculada Fernandez Vazquez, M. Prieto, Xavier Torras, Jose Miguel Rosales Zabal, Lourdes Grande Santamaria, Rosa Morillas, Moises Diago, Beatriz de Cuenca Moron, Manuel Delgado, Lucia Bonet, Juan Turnes, Javier Crespo, Carme Baliellas, Jose Luis Calleja Panero, Esther Badia-Aranda, Juan Manuel Pascasio, Jose Maria Moreno, Vanesa Bernal Monterde, Isabel Carmona, Miguel Fernandez-Bermejo, Rosa Quiles, Pablo Bellot Garcia, Jesus M. Gonzalez-Santiago, Maria Luisa Gutierrez, Jose Juan Moreno, Ma Dolores Anton Conejero, Juan De la Vega, Desamparados Escudero-Garcia, Juan Arenas, Jose A. Carrion

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection

Joaquin Cabezas, Inmaculada Fernandez Vazquez, Susana Llerena, Jose A. Carrion, Adolfo Gallego Moya, Sabela Lens, Jose Luis Calleja Panero, Juan Manuel Pascasio, M. Prieto, Francisco Gea, Jose Maria Moreno-Planas, Isabel Carmona, Diego Rincon, Esther Badia-Aranda, Moises Diago, Rosa Morillas, Juan Turnes, Juan Arenas, Ana Arencibia, Javier Crespo

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

Qian Chen, Celia Perales, Maria Eugenia Soria, Damir Garcia-Cehic, Josep Gregori, Francisco Rodriguez-Frias, Maria Buti, Javier Crespo, Joe Luis Calleja, David Tabernero, Marta Vila, Fernando Lazaro, Ariadna Rando-Segura, Leonardo Nieto-Aponte, Meritxell Llorens-Revull, Maria Francesca Cortese, Irati Fernandez-Alonso, Jose Castellote, Jordi Niubo, Arkaitz Imaz, Xavier Xiol, Lluis Castells, Mar Riveiro-Barciela, Jordi Llaneras, Jordi Navarro, Victor Vargas-Blasco, Salvador Augustin, Isabel Conde, Angel Rubin, Martin Prieto, Xavier Torras, Nuria Margall, Xavier Forns, Zoe Marino, Sabela Lens, Martin Bonacci, Sofia Perez-del-Pulgar, Maria Carlota Londono, Maria Luisa Garcia-Buey, Paloma Sanz-Cameno, Rosa Morillas, Elisa Martro, Veronica Saludes, Helena Masnou-Ridaura, Javier Salmeron, Rosa Quiles, Jose Antonio Carrion, Montserrat Forne, Merce Rosinach, Inmaculada Fernandez, Javier Garcia-Samaniego, Antonio Madejon, Pilar Castillo-Grau, Carme Lopez-Nunez, Maria Jose Ferri, Rosa Durandez, Federico Saez-Royuela, Moises Diago, Concepcion Gimeno, Rafael Medina, Juan Buenestado, Albert Bernet, Juan Turnes, Matilde Trigo-Daporta, Manuel Hernandez-Guerra, Manuel Delgado-Blanco, Angelina Canizares, Juan Ignacio Arenas, Maria Juana Gomez-Alonso, Manuel Rodriguez, Elisabet Deig, Gemma Olive, Oscar del Rio, Joaquin Cabezas, Ildefonso Quinones, Merce Roget, Silvia Montoliu, Juan Garcia-Costa, Lluis Force, Silvia Blanch, Miguel Miralbes, Maria Jose Lopez-de-Goicoechea, Angels Garcia-Flores, Maria Saumoy, Teresa Casanovas, Carme Baliellas, Pau Gilabert, Albert Martin-Cardona, Rosa Roca, Merce Barenys, Joana Villaverde, Silvia Salord, Blau Camps, Maria Silvan di Yacovo, Imma Ocana, Silvia Sauleda, Marta Bes, Judit Carbonell, Elena Vargas-Accarino, Sofia P. Ruzo, Mercedes Guerrero-Murillo, Georg Von Massow, Maria Isabel Costafreda, Rosa Maria Lopez, Leticia Gonzalez-Moreno, Yolanda Real, Doroteo Acero-Fernandez, Silvia Viroles, Xavier Pamplona, Mireia Cairo, Maria Dolores Ocete, Jose Francisco Macias-Sanchez, Angel Estebanez, Joan Carles Quer, Alvaro Mena-de-Cea, Alejandra Otero, Angeles Castro-Iglesias, Francisco Suarez, Angeles Vazquez, David Vieito, Soledad Lopez-Calvo, Pilar Vazquez-Rodriguez, Francisco Jose Martinez-Cerezo, Raul Rodriguez, Ramiro Macenlle, Alba Cachero, Gasshan Mereish, Carme Mora-Moruny, Silvia Fabregas, Begona Sacristan, Agustin Albillos, Juan Jose Sanchez-Ruano, Raquel Baluja-Pino, Javier Fernandez-Fernandez, Carlos Gonzalez-Portela, Carmen Garcia-Martin, Gloria Sanchez-Antolin, Raul Jesus Andrade, Miguel Angel Simon, Juan Manuel Pascasio, Manolo Romero-Gomez, Jose Antonio del-Campo, Esteban Domingo, Rafael Esteban, Juan Ignacio Esteban, Josep Quer

ANTIVIRAL RESEARCH (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)

Manuel Rodriguez, Maria Buti, Rafael Esteban, Sabela Lens, Martin Prieto, Emilio Suarez, Javier Garcia-Samaniego

GASTROENTEROLOGIA Y HEPATOLOGIA (2020)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19

J. Del Hoyo, P. Lopez-Munoz, M. Fernandez-de la Varga, A. Garrido-Marin, E. Valero-Perez, M. Prieto, V Aguilera

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Meeting Abstract Immunology

HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study

C. Vinaixa, V Aguilera, J. Herreras, T. Di Maira, M. Blanes, M. Berenguer, M. Prieto

TRANSPLANTATION (2019)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.

Juan Manuel Pascasio Acevedo, Lorena Puchades, Carmen Sendra, Lluis Castells, Maria Magdalena Salcedo Plaza, Julia Herreras, Flor Nogueras Sanchez, Ana Arias, Carme Baliellas, Alejandra Otero, Elena Oton, Emilio Fabrega, Fernando Diaz-Fontenla, Inmaculada Fernandez, Maria Luisa Gonzalez Dieguez, Jose Antonio Pons, Isidoro Narvaez, Beatriz Mateos, Sonia Pascual, Martin Prieto, Jose Manuel Sousa

HEPATOLOGY (2019)

添加到收藏夹

Correction Surgery

Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)

C. Manzardo, M. C. Londono, L. Castells, M. Testillano, J. Luis Montero, J. Penafiel, M. Subirana, A. Moreno, V Aguilera, M. Luisa Gonzalez-Dieguez, J. Calvo-Pulido, X. Xiol, M. Salcedo, V Cuervas-Mons, J. Manuel Sousa, F. Suarez, T. Serrano, J. Ignacio Herrero, M. Jimenez, J. R. Fernandez, C. Gimenez, S. Del Campo, J. Esteban-Mur, G. Crespo, A. Moreno, G. de la Rosa, A. Rimola, J. M. Miro, F. Suarez, M. A. Castro, S. Lopez, J. D. Pedreira, P. Vazquez, F. Aguero, J. Blanch, M. Brunet, D. Calatayud, C. Cervera, E. de Lazzari, C. Fondevila, A. Forner, J. Fuster, X. Forns, A. Gil, J. M. Gatell, M. Laguno, A. Lligona, J. Mallolas, J. Murillas, M. Navasa, D. Paredes, I Perez, F. Torres, C. Tural, M. Tuset, A. Antela, E. Losada, E. Molina, E. Otero, E. Varo, J. J. Araiz, E. Barrao, J. Larraga, S. Letona, R. Lozano, P. Luque, A. Navarro, I Sanjoaquin, E. Tejero, R. Banares, J. Berenguer, G. Clemente, J. Cosin, J. P. Ferreiroa, J. L. Garcia-Sabrido, I Gutierrez, J. C. Lopez, P. Miralles, M. Ramirez, D. Rincon, M. Sanchez, J. de la Cruz, J. L. Fernandez, J. M. Lozano, J. Santoyo, J. M. Rodrigo, M. A. Suarez, M. Rodriguez, M. P. Alonso, V Asensi, I Gonzalez-Pinto, A. Rafecas, C. Baliellas, J. Carratala, J. Fabregat, N. Fernandez, R. Jorba, L. Llado, M. Montejo, J. Bustamante, J. R. Fernandez, M. Gastaca, J. Gonzalez, E. Montejo, J. Ortiz de Urbina, P. Ruiz, M. J. Suarez, A. Valdivieso, A. Ventoso, M. Abradelo, J. Calvo, J. R. Costa, A. Garcia-Sesma, C. Jimenez, A. Manrique, J. C. Meneu, E. Moreno, V Moreno, S. P. Olivares, F. Pulido, R. Rubio, M. Blanes, M. Berenguer, J. Lopez, R. Lopez, M. Prieto, M. C. Farinas, F. Casafont, S. Echevarria, E. Fabrega, M. Gomez-Fleitas, C. Arminanzas, J. L. Herrera-Norena, S. Moreno, R. Barcena, J. Fortun, A. M. Moreno, P. Martin-Davila, J. Torre-Cisneros, P. Barrera, J. Briceno, J. J. Caston, G. Costan, M. de la Mata, R. Lara, P. Lopez-Cillero, A. Rivero, S. Rufian, G. Sanchez-Antolin, F. Garcia Pajares, P. Bachiller, C. Almohalla, A. Barrera, R. Conde, I Bilbao, I Campos-Varela, R. Charco, J. Esteban, J. Gavalda, O. Len, A. Pahissa, E. Ribera, V. Vargas, J. A. Pons, E. Cordero, C. Bernal, J. M. Cisneros, M. A. Gomez, J. M. Pascasio, M. J. Rodriguez, M. Sayago, G. Suarez, J. Gonzalez-Garcia, E. Aznar, H. Esteban, B. Moyano, G. Garrido, B. Mahillo, R. Matesanz, L. Guerra, M. Manzanera, D. Samuel

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Pangenotypic Treatment of Chronic Hepatitis C: Results from a Spanish Cohort (Hepa-C)

Marc Puigvehi, Agustin Albillos, Ana Viu, Manuel Nicolas Hernandez Guerra, Inmaculada Fernandez, Martin Prieto, Xavier Torras Collell, Jose Miguel Rosales Zabal, Lourdes Grande, Rosa Morillas, Moises Diago, Beatriz De Cuenca, Manuel Delgado, Lucia Bonet, Juan Turnes, Javier Crespo, Carme Baliellas, Jose Luis Calleja, Ester Badia, Juan Manuel Pascasio, Jose Maria Moreno Planas, Vanesa Bernal, Isabel Carmona, Miguel Fernandez, Javier Salmeron, Pablo Bellot, Jesus M. Gonzalez-Santiago, Maria Luisa Gutierrez, J. Javier Moreno, Maria Dolores Anton, Juan De La Vega, Desamparados Escudero-Garcia, Juan Arenas, Jose Antonio Carrion

HEPATOLOGY (2018)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

HIV Infection Is Not Associated with Increased Cardiovascular Risk in Liver Transplant Recipients: A Single Center Comparative Study

Julia Herreras, Victoria Aguilera, Carmen Vinaixa, Martin Prieto, Marina Berenguer

HEPATOLOGY (2018)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

Universal Access to Daa-Treatment Is Not Enough to Prevent Late Stage Presentation of HCV Infection.

Joaquin Cabezas, Inmaculada Fernandez, Susana Llerena, Jose Antonio Carrion, Adolfo Gallego, Jose Luis Calleja, Sabela Lens, Juan Manuel Pascasio, Martin Prieto, Francisco Gea, Jose Maria Moreno-Planas, Isabel Carmona, Diego Rincon, Ester Badia, Moises Diago, Rosa Morillas, Juan Turnes, Juan Arenas, Ana C. Arencibia, Javier Crespo

HEPATOLOGY (2018)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.